No Data
China Grand Pharmaceutical and Healthcare Holdings Limited (01672.HK) spent 0.287 million Hong Kong dollars to repurchase 0.171 million shares on December 3.
Glory Pharmaceutical-B (01672.HK) announced on December 3 that it repurchased 0.171 million shares for 0.287 million Hong Kong dollars on December 3.
Repurchase collection on December 2nd | Tencent, AIA and other companies have successively repurchased, with Tencent spending HKD 0.701 billion.
According to the document disclosed by hkex on December 3, $tencent (00700.HK)$, $aia (01299.HK)$ and others repurchased shares. ① $tencent (00700.HK)$ repurchased 1.76 million ordinary shares on December 2, involving an amount of 0.701 billion HKD, with a repurchase price ranging from 401.2 HKD to 395.6 HKD per share. Since the repurchase authorization resolution, the total number of securities repurchased has reached 0.199 billion shares, accounting for 2.11% of the total issued shares at the time the ordinary resolution was passed. ② $aia (01299.HK)$ repurchased on December
China Grand Pharmaceutical and Healthcare Holdings Limited (01672) spent approximately 0.8116 million Hong Kong dollars to repurchase 0.5 million shares on December 2.
Gere Pharmaceutical-B (01672) announced that it will spend approximately 0.8116 million Hong Kong dollars to repurchase 50... on December 2, 2024.
Repurchase summary on November 27 | tencent, aia and others have repurchased shares, with tencent spending 0.704 billion HKD.
According to the documents disclosed by hkex on November 28, $tencent (00700.HK)$, $aia (01299.HK)$ and others repurchased shares. ① $tencent (00700.HK)$ repurchased 1.77 million ordinary shares on November 27, involving an amount of 0.704 billion Hong Kong dollars, with a repurchase price ranging from 405.8 Hong Kong dollars to 392.2 Hong Kong dollars per share. Since the repurchase authorization resolution, the cumulative number of repurchased securities has reached 0.193 billion shares, accounting for 2.054% of the number of shares issued at the time the ordinary resolution was passed. ② $aia (01299.HK)$
On November 27, Gilai Pharmaceuticals-B (01672.HK) spent 0.993 million Hong Kong dollars to repurchase 0.6 million shares.
On November 27, Geloan Hui reported that Gilead Sciences-B (01672.HK) announced it spent HKD 0.993 million to repurchase 0.6 million shares.
Repurchase summary on November 26 | tencent, hsbc holdings and others have repurchased shares, among which tencent spent 0.703 billion HKD.
According to documents disclosed by hkex on November 27, tencent holdings (00700.HK), hsbc holdings (00005.HK), and others repurchased shares. ① Tencent Holdings (00700.HK) repurchased 1.78 million shares of common stock on November 26, involving an amount of 0.703 billion Hong Kong dollars, with a repurchase price per share ranging from 399 Hong Kong dollars to 392.2 Hong Kong dollars. Since the repurchase authorization resolution, the total number of repurchased securities is 0.192 billion shares, accounting for 2.035% of the number of issued shares when the ordinary resolution was passed. ② Hsbc Holdings (00005.HK) on 1
